| content | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cyclin L1
|
|||||||||||
| Identifiers | |||||||||||
| Symbols | CCNL1; PRO1073; BM-001; ania-6a | ||||||||||
| External IDs | MGI: 1922664 HomoloGene: 10541 | ||||||||||
|
|||||||||||
| RNA expression pattern | |||||||||||
|
|
|||||||||||
| Orthologs | |||||||||||
| Human | Mouse | ||||||||||
| Entrez | 57018 | 56706 | |||||||||
| Ensembl | ENSG00000163660 | ENSMUSG00000027829 | |||||||||
| Uniprot | Q9UK58 | Q52KE7 | |||||||||
| Refseq | NM_020307 (mRNA) NP_064703 (protein) |
NM_019937 (mRNA) NP_064321 (protein) |
|||||||||
| Location | Chr 3: 158.35 - 158.36 Mb | Chr 3: 66.03 - 66.05 Mb | |||||||||
| Pubmed search | [1] | [2] | |||||||||
Cyclin L1, also known as CCNL1, is a human gene.[1]
References
Further reading
- Zhang QH, Ye M, Wu XY, et al. (2001). "Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.". Genome Res. 10 (10): 1546–60. PMID 11042152.
- Berke JD, Sgambato V, Zhu PP, et al. (2001). "Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin.". Neuron 32 (2): 277–87. PMID 11683997.
- Dickinson LA, Edgar AJ, Ehley J, Gottesfeld JM (2002). "Cyclin L is an RS domain protein involved in pre-mRNA splicing.". J. Biol. Chem. 277 (28): 25465–73. doi:. PMID 11980906.
- Redon R, Hussenet T, Bour G, et al. (2002). "Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer.". Cancer Res. 62 (21): 6211–7. PMID 12414649.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.". Genome Res. 13 (10): 2265–70. doi:. PMID 12975309.
- de Graaf K, Hekerman P, Spelten O, et al. (2004). "Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors.". J. Biol. Chem. 279 (6): 4612–24. doi:. PMID 14623875.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:. PMID 14702039.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins.". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:. PMID 15302935.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:. PMID 15489334.
- Sticht C, Hofele C, Flechtenmacher C, et al. (2005). "Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC).". Br. J. Cancer 92 (4): 770–4. doi:. PMID 15700036.
- Muller D, Millon R, Théobald S, et al. (2006). "Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma.". Br. J. Cancer 94 (7): 1041–4. doi:. PMID 16598186.
 |
This article on a gene on chromosome 3 is a stub. You can help Wikipedia by expanding it. |
